Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Dolsten Mikael
Over the trailing 90 days, Dolsten Mikael (Other at Apellis Pharmaceuticals, Inc.) sold $217K of stock across 3 companies, per 6 SEC Form 4 transactions.
- Role
- Other
- Window
- Trailing 90 days · 6 transactions · CIK 1437590
- Net activity
- −$217K ($0 bought · $217K sold)
By Company (Trailing 90 Days)
Transactions (6)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-06-18 | RCKT | Buy | 22.9K | $0 | Grant, award or other acquisition |
| 2026-06-18 | RCKT | Buy | 64.9K | $0 | Grant, award or other acquisition |
| 2026-05-29 | A | Sell | 1.6K | $217K | Open market or private sale |
| 2026-05-14 | APLS | Sell | 14.3K | $0 | Disposition to the issuer of issuer equity securities |
| 2026-05-14 | APLS | Sell | 14.3K | $0 | Disposition pursuant to a tender of shares |
| 2026-05-14 | APLS | Sell | 24.1K | $0 | Disposition to the issuer of issuer equity securities |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Dolsten's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.